 | • レポートコード：TPM-B06063 • 出版社/出版日：Transparency Market Research / 2018年5月15日 • レポート形態：英文、PDF、179ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、歯周治療の世界市場について調べ、歯周治療の世界規模、市場動向、市場環境、製品タイプ別（全身性抗生物質、局所抗生物質）分析、販売チャネル別（院内薬局、小売薬局、ドラッグストア、電子商取引）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・歯周治療の世界市場動向 ・歯周治療の世界市場環境 ・歯周治療の世界市場規模 ・歯周治療の世界市場規模：製品タイプ別（全身性抗生物質、局所抗生物質） ・歯周治療の世界市場規模：販売チャネル別（院内薬局、小売薬局、ドラッグストア、電子商取引） ・歯周治療の世界市場：地域別市場規模・分析 ・歯周治療の北米市場規模・予測 ・歯周治療のアメリカ市場規模・予測 ・歯周治療の中南米市場規模・予測 ・歯周治療のヨーロッパ市場規模・予測 ・歯周治療のアジア市場規模・予測 ・歯周治療の日本市場規模・予測 ・歯周治療の中国市場規模・予測 ・歯周治療のインド市場規模・予測 ・歯周治療の中東市場規模・予測 ・歯周治療のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Periodontal Therapeutics Market – Overview
Periodontal therapeutics are effective adjunctive therapies used in the treatment of periodontal pathogens. These therapies include systemic antibiotics, such as doxycycline, minocycline, metronidazole, and other antibiotics comprising amoxicillin, azithromycin, etc. and local antibiotics, including Arestin, Atridox, PerioChip, and others. This report analyzes the current and future prospects of the periodontal therapeutics market based on product type, distribution channel, and geography.
This study is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the periodontal therapeutics market in the near future. Primary research formed the bulk of our research efforts, with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation, and various international and national databases. The report provides estimated market size in terms of US$ Mn (US$ in million) for product type, distribution channel, and geography for the period of 2018 to 2026.
The report contains an elaborative executive summary, which includes market snapshot providing information on various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, distribution channel, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that can influence the periodontal therapeutics market in the current and future scenario. The report also provides Porter’s five force analysis that studies five factors and their impact on the periodontal therapeutics market.
Market share of key players is analyzed to signify the contribution of these players toward the revenue of the market. As such, these factors are likely to help market players in deciding about business strategies and plans for strengthening their position in the global market. Based on geography, the market has been analyzed for five major regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. The study also covers detailed country analysis in these regions for the periodontal therapeutics market.
The report also profiles major players in the periodontal therapeutics market and provides their key attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, and Kaken Pharmaceutical Co., Ltd. Inorganic growth measurements and business collaborations were the primary strategies adopted by the major market players to cement their position in the periodontal therapeutics market.
The periodontal therapeutics market has been segmented as follows:
Periodontal Therapeutics Market, by Product Type, Revenue (US$ Mn) 2018-2026
Systemic Antibiotics
Doxycycline
Minocycline
Metronidazole
Others
Local Antibiotics
Arestin
Atridox
PerioChip
Others
Periodontal Therapeutics Market, by Distribution Channel, Revenue (US$ Mn) 2018-2026
Hospital Pharmacies
Retail Pharmacies
Drug Stores
E-commerce
Periodontal Therapeutics Market, by Geography, Revenue (US$ Mn), 2018-2026
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Periodontal Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Periodontal Therapeutics Market Analysis and Forecast, 2016–2026
4.5. Porter’s Five Force Analysis
5. Market Outlook
6. Global Periodontal Therapeutics Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Systemic Antibiotics
6.3.1.1. Doxycycline
6.3.1.2. Minocycline
6.3.1.3. Metronidazole
6.3.1.4. Others
6.3.2. Local Antibiotics
6.3.2.1. Arestin
6.3.2.2. Atridox
6.3.2.3. PerioChip
6.3.2.4. Others
6.4. Market Attractiveness, by Product
7. Global Periodontal Therapeutics Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Distribution Channel, 2016–2026
7.3.1. Hospitals Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Drug Stores
7.3.4. E-commerce
7.4. Market Attractiveness, by Distribution Channel
8. Global Periodontal Therapeutics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region/Sub-region
9. North America Periodontal Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2016–2026
9.2.1. Systemic Antibiotics
9.2.1.1. Doxycycline
9.2.1.2. Minocycline
9.2.1.3. Metronidazole
9.2.1.4. Others
9.2.2. Local Antibiotics
9.2.2.1. Arestin
9.2.2.2. Atridox
9.2.2.3. PerioChip
9.2.2.4. Others
9.3. Market Value Forecast, by Distribution Channel, 2016–2026
9.3.1. Hospitals Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Drug Stores
9.3.4. E-commerce
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. by Product
9.5.2. by Distribution Channel
9.5.3. by Country
10. Europe Periodontal Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Systemic Antibiotics
10.2.1.1. Doxycycline
10.2.1.2. Minocycline
10.2.1.3. Metronidazole
10.2.1.4. Others
10.2.2. Local Antibiotics
10.2.2.1. Arestin
10.2.2.2. Atridox
10.2.2.3. PerioChip
10.2.2.4. Others
10.3. Market Value Forecast, by Distribution Channel, 2016–2026
10.3.1. Hospitals Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Drug Stores
10.3.4. E-commerce
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. by Product
10.5.2. by Distribution Channel
10.5.3. by Country
11. Asia Pacific Periodontal Therapeutics Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Systemic Antibiotics
11.2.1.1. Doxycycline
11.2.1.2. Minocycline
11.2.1.3. Metronidazole
11.2.1.4. Others
11.2.2. Local Antibiotics
11.2.2.1. Arestin
11.2.2.2. Atridox
11.2.2.3. PerioChip
11.2.2.4. Others
11.3.Market Value Forecast, by Distribution Channel, 2016–2026
11.3.1. Hospitals Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Drug Stores
11.3.4. E-commerce
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis
11.5.1. by Product
11.5.2. by Distribution Channel
11.5.3. by Country
12. Latin America Periodontal Therapeutics Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Systemic Antibiotics
12.2.1.1. Doxycycline
12.2.1.2. Minocycline
12.2.1.3. Metronidazole
12.2.1.4. Others
12.2.2. Local Antibiotics
12.2.2.1. Arestin
12.2.2.2. Atridox
12.2.2.3. PerioChip
12.2.2.4. Others
12.3.Market Value Forecast, by Distribution Channel, 2016–2026
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Drug Stores
12.3.4. E-commerce
12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis
12.5.1. by Product
12.5.2. by Distribution Channel
12.5.3. by Country
13. Middle East & Africa Periodontal Therapeutics Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Systemic Antibiotics
13.2.1.1. Doxycycline
13.2.1.2. Minocycline
13.2.1.3. Metronidazole
13.2.1.4. Others
13.2.2. Local Antibiotics
13.2.2.1. Arestin
13.2.2.2. Atridox
13.2.2.3. PerioChip
13.2.2.4. Others
13.3.Market Value Forecast, by Distribution Channel, 2016–2026
13.3.1. Hospitals Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Drug Stores
13.3.4. E-commerce
13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis
13.5.1. by Product
13.5.2. by Distribution Channel
13.5.3. by Country
14. Competition Landscape
14.1.Market Player – Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis, by Company (2017)
14.3. Competitive Business Strategies
14.4. Company Profiles
14.4.1. 3M Company
14.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.1.2. Business Overview
14.4.1.3. Product Portfolio
14.4.1.4. Financial Overview
14.4.1.5. SWOT Analysis
14.4.1.6. Strategic Overview
14.4.2. Den-Mat Holdings, LLC
14.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.2.2. Business Overview
14.4.2.3. Product Portfolio
14.4.2.4. Financial Overview
14.4.2.5. SWOT Analysis
14.4.2.6. Strategic Overview
14.4.3. Dexcel Pharma
14.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.3.2. Business Overview
14.4.3.3. Product Portfolio
14.4.3.4. Financial Overview
14.4.3.5. SWOT Analysis
14.4.3.6. Strategic Overview
14.4.4. Kaken Pharmaceutical Co., Ltd.
14.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.4.2. Business Overview
14.4.4.3. Product Portfolio
14.4.4.4. Financial Overview
14.4.4.5. SWOT Analysis
14.4.4.6. Strategic Overview
14.4.5. Oral Science
14.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.5.2. Business Overview
14.4.5.3. Product Portfolio
14.4.5.4. Financial Overview
14.4.5.5. SWOT Analysis
14.4.5.6. Strategic Overview
14.4.6. Valeant Pharmaceuticals International, Inc.
14.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.4.6.2. Business Overview
14.4.6.3. Product Portfolio
14.4.6.4. Financial Overview
14.4.6.5. SWOT Analysis
14.4.6.6. Strategic Overview
Table 01: Price Competitiveness between Atridox and Arestin
Table 02: Global Pipeline Analysis – Periodontal Therapeutics Drugs Market
Table 03: Global Periodontal Therapeutics Pipeline Drugs Market Size (US$ Mn) Forecast, 2019–2026
Table 04: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 05: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 06: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 07: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Global Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 09: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 11: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 12: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 13: North America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 14: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 15: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 16: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 17: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 18: Europe Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 19: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 20: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 21: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 22: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 23: Asia Pacific Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 24: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 25: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 26: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 27: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 28: Latin America Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 29: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 30: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 31: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Systemic Antibiotics, 2016–2026
Table 32: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Local Antibiotics, 2016–2026
Table 33: Middle East & Africa Periodontal Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026